Abvc Biopharma (ABVC) Receivables - Other (2017 - 2026)
Abvc Biopharma (ABVC) reported Receivables - Other of $36,184 for Q2 2026, down 97.5% from $1.42 million a year earlier and down 78.4% from the prior quarter.
Powered by 
Analysis
Abvc Biopharma (ABVC) Receivables - Other (2017 - 2026) Analysis & Trends
At the end of FY2025, Abvc Biopharma posted Receivables - Other of $1.53 million.
- Receivables - Other has a five-year compound annual growth rate of 60.5% (FY2020 to FY2025).
- By year, Receivables - Other came in at $747,573 in FY2023 (-1.3%), $757,343 in FY2022 (+420.9%) and $145,399 in FY2021 (+1.4%).
- Five-year quarterly Receivables - Other spans a low of $546.00 in Q3 2025 and a high of $2.84 million in Q2 2024.
- Year over year, Receivables - Other gained in 1 of the last six quarters, with an average decline of 46.4%.
- The high point for year-over-year Receivables - Other in five years was Q2 2024 (growth of 440.6%); the low point was Q3 2025 (a decline of 100.0%).
- Per Business Quant data, the three quarters before Q2 2026 came in at $167,324 (Q1 2026), $2,347 (Q4 2025) and $546.00 (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn |
| 10 | Abvc Biopharma | 27.31 Mn | 29.30 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 36,184.00 |
| Mar 31, 2026 | 167,324.00 |
| Dec 31, 2025 | 2,347.00 |
| Sep 30, 2025 | 546.00 |
| Jun 30, 2025 | 1.42 Mn |
| Mar 31, 2025 | 1.07 Mn |
| Sep 30, 2024 | 1.20 Mn |
| Jun 30, 2024 | 2.84 Mn |
| Mar 31, 2024 | 1.78 Mn |
| Dec 31, 2023 | 2,667.00 |
| Sep 30, 2023 | 624,373.00 |
| Jun 30, 2023 | 526,216.00 |
| Mar 31, 2023 | 519,984.00 |
| Dec 31, 2022 | 757,343.00 |
| Jun 30, 2022 | 142,225.00 |
| Mar 31, 2022 | 145,399.00 |
| Dec 31, 2021 | 145,399.00 |
| Sep 30, 2021 | 141,826.00 |
| Jun 30, 2021 | 145,475.00 |
| Mar 31, 2021 | 702,889.00 |
API Access
Abvc Biopharma Receivables - Other API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=receivables-other&ticker=ABVC&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "receivables-other", "ticker": "ABVC", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=receivables-other&ticker=ABVC&period=max&api_key=YOUR_API_KEY");
const data = await res.json();